EAM
AMHCU

Exos Asset Management’s Amplitude Healthcare Acquisition Corporation Unit AMHCU Stock Holding History

Exos Asset Management’s Portfolio AMHCU Stock Details AMHCU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,300
Closed -$14K – 566
2020
Q4 		$14K Buy
+1,300
New +$14K 0.02% 216

Other funds holding AMHCU

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Exos Asset Management's AMHCU Position: Q1 2021 in Review

Exos Asset Management sold out of Amplitude Healthcare Acquisition Corporation Unit (AMHCU) in Q1 2021, closing a stake of 1,300 shares — an estimated $14K sold.

Exos Asset Management first reported a position in AMHCU in Q4 2020 and held it in 1 quarter. The position peaked at $14K in Q4 2020. 8 funds tracked by Wall St. Rank hold AMHCU as of Q1 2021.

  • Exos Asset Management reported no remaining Amplitude Healthcare Acquisition Corporation Unit position as of Q1 2021 after selling out during the quarter.
  • Exos Asset Management sold 1,300 Amplitude Healthcare Acquisition Corporation Unit shares in Q1 2021, an estimated $14K.
  • Exos Asset Management first reported a position in Amplitude Healthcare Acquisition Corporation Unit in Q4 2020 and held it in 1 quarter.
  • Exos Asset Management's Amplitude Healthcare Acquisition Corporation Unit position peaked at $14K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Amplitude Healthcare Acquisition Corporation Unit as of Q1 2021.

Based on Exos Asset Management's 13F filing for Q1 2021, filed 5 May 2021.